Delivery Order SPE2DB20D1100-SPE2DB24FB6R2
Award Date
5/7/24
Potential Completion Date
5/8/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,637.20 and an ultimate completion date of February 7, 2025. The contract covers the procurement of BUTALB-ACETAMIN-CAFF 50-325-40 100S, a medical product, with no set-aside designation indicated. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,176.38 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide BUTALB-ACETAMIN-CAFF 50-325-40 100S medical products. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.20 firm fixed-price delivery order is for the supply of BUTALB-ACETAMIN-CAFF 50-300-40 100S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,017.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 28, 2025. The contract covers the procurement of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,306.93 firm fixed-price delivery order contract is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S medical products. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This contract award, valued at $3,293.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. It is a delivery order contract for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S pharmaceutical products. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, including the military and...
This federal contract award, valued at $4,033.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed-price pricing type. The award has an ultimate completion date of August 22, 2024. No set-aside designation is mentioned. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,724.24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,474.20 with a firm fixed price and an ultimate completion date of February 21, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567331087 - BUTALB-ACETAMIN-CAFF 50-325-40 100S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,132.58 firm fixed-price delivery order is for the supply of the drug "BUTALB-ACETAMIN-CAF-COD 50-300 100S" and has a completion date of June 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...